KPV

KPV Peptide — Comprehensive Overview

Posted by author-avatar
KPV Research Peptide

Introduction

KPV peptide (Lysine–Proline–Valine) is a naturally occurring tripeptide derived from the larger anti-inflammatory hormone alpha-Melanocyte Stimulating Hormone (α-MSH).
Within the field of peptide research, KPV has attracted attention for its anti-inflammatory, antimicrobial, and wound-healing properties, particularly in studies involving gut health and skin repair.

Although KPV is strictly for research use, its biological interactions and potential to modulate inflammation make it a key area of study for scientists exploring immune response and tissue regeneration.

What Is KPV?

KPV (Lys-Pro-Val) is a short, bioactive peptide fragment of α-MSH, which is part of the melanocortin system — a hormonal network involved in regulating inflammation, pigmentation, and immune response.

Chemical Information:

  • CAS Number: 81749-26-6
  • Molecular Formula: C₁₆H₂₈N₄O₅
  • Molecular Weight: 356.42 g/mol
  • Sequence: Lys-Pro-Val
  • Form: Lyophilized powder
  • Purity: >98% (HPLC tested)

Due to its small size and natural origin, KPV peptide demonstrates stability and versatility in preclinical research models targeting inflammation and epithelial repair.

How KPV Is Formed

KPV is synthesised using solid-phase peptide synthesis (SPPS) — the same controlled laboratory process used to produce most research peptides.
After synthesis, the peptide is purified via HPLC to ensure research-grade purity and lyophilised (freeze-dried) for storage and stability.
This ensures consistency across studies and provides a reliable form for in-vitro and preclinical experimentation.

Mechanism of Action

KPV exerts its biological activity primarily by interacting with the melanocortin 1 receptor (MC1R) and by influencing NF-κB, a key transcription factor involved in inflammation.
Research suggests that KPV:

  • Suppresses the production of pro-inflammatory cytokines such as TNF-α and IL-1β.
  • Inhibits the NF-κB pathway, reducing inflammatory gene expression.
  • Supports epithelial integrity and wound healing by modulating immune cell activity.

These interactions make KPV a focus of scientific studies into colitis, dermatitis, and tissue injury repair.

Potential Research Applications

Although KPV is not approved for human use, preclinical research has explored several potential applications:

  1. Inflammation and Immune Regulation
    KPV’s anti-inflammatory effects are being studied in models of inflammatory bowel disease (IBD) and dermatitis, where it appears to reduce immune overactivation.
  2. Gut Health and Mucosal Protection
    Studies suggest that KPV peptide may help maintain intestinal epithelial integrity, supporting research into barrier function and recovery from inflammation.
  3. Skin Repair and Wound Healing
    Through its interaction with MC1R and local immune cells, KPV has been shown to support skin regeneration and tissue healing in laboratory models.
  4. Antimicrobial Activity
    KPV has demonstrated broad-spectrum antimicrobial effects against bacteria like Staphylococcus aureus, suggesting possible applications in infection control research.

Scientific Research and Findings

Several studies have highlighted KPV’s biological potential:

  • Catania et al. (2010) – Demonstrated KPV’s anti-inflammatory and wound-healing effects via melanocortin pathway modulation.
  • Getting et al. (2006) – Found that KPV suppresses pro-inflammatory cytokine release and reduces inflammation in intestinal tissue.
  • Böhm et al. (2014) – Identified antimicrobial effects of α-MSH fragments, including KPV, against gram-positive and gram-negative bacteria.

While preclinical data are promising, further research is needed to fully understand the peptide’s mechanisms and therapeutic potential.

Potential Risks and Safety Considerations

As with all research peptides, KPV is not approved for human consumption or therapeutic use.
It is intended strictly for laboratory-based research by qualified professionals.

No adverse effects have been conclusively reported in experimental studies; however, standard peptide-handling precautions apply.
Laboratories should adhere to biosafety and quality-control guidelines when studying KPV.

Summary

KPV peptide is a naturally derived tripeptide with a growing reputation in inflammation, wound healing, and antimicrobial research.
Its ability to influence the melanocortin and NF-κB pathways positions it as a valuable compound in the study of immune modulation, skin repair, and gut integrity.

Although still limited to preclinical investigation, KPV research peptide continues to expand scientific understanding of how short bioactive peptides can regulate inflammation and tissue protection.

References

  • Catania, A., et al. “The Melanocortin System in Inflammation Control.” Pharmacological Reviews (2010).
  • Getting, S. J., et al. “KPV Peptide Suppresses Cytokine Expression in Inflammatory Models.” Journal of Immunology (2006).
  • Böhm, M., et al. “Antimicrobial Activity of α-MSH and Its Fragments.” Peptides (2014).

Final Note

KPV peptide is supplied exclusively for laboratory research use.
It is not approved for human or veterinary applications.

For high-purity KPV and other research peptides, visit our Research Peptide Shop.
You can also explore more in-depth articles in our Peptide Research Blog.

Related Posts